Firms
OSF Ventures
Peoria, Illinois, United States
Corporate venture investment unit of OSF HealthCare, operating within OSF Innovation in Peoria, Illinois. OSF Ventures invests in post-seed healthcare companies through investment syndicates and works with OSF clinicians and operating teams to test, refine and adopt technologies that may improve patient outcomes and patient experience or reduce the cost of care. Its focus includes health IT, medical devices, therapeutics, diagnostics and technology-enabled care delivery. Its AI and neuroscience portfolio includes autonomous diagnostic AI, wearable EEG and machine learning, bioelectronic medicine, migraine neuromodulation, AI-assisted clinical decisions and ultrasound imaging. The unit was founded in the last quarter of 2015 and began its first $75 million investment program in 2016. A second $75 million corporate fund launched in July 2019 and a third board-approved $100 million fund launched in January 2022, bringing the program’s reported capital under management to $250 million at that time. These are corporate capital allocations and fund launches, rather than asserted outside-LP fundraising closes. Its official portfolio separates direct companies, exited companies and investments as a limited partner in external healthcare funds. The current main-page team names seven people: vice president Mayank Taneja, directors Liridon Rrushaj and Ben Spektor, manager Danielle Kalinsky, senior venture analyst Samuel Martin, venture analyst Jeremy Snell and project assistant Elizabeth Eaker. The parent OSF HealthCare organization is preserved separately from this branded investment unit; the unit profile uses the authentic shared OSF HealthCare brand mark displayed on its own official page.
- Founded
- 2015
- Type
- Venture capital
Funds3
Team
Operations and support
 Ben SpektorDirector, Venture Investments |
 Danielle KalinskyManager of Venture Investments |
 Elizabeth EakerProject Assistant |
 Jeremy SnellVenture Analyst |
 Liridon RrushajDirector, Venture Investments |
 Mayank TanejaVice President, Venture Investments |
 Samuel MartinSenior Venture Analyst |
Co-investing
8VC
Digital Diagnostics$75M · 2022-08-23
Birchview Capital
Monteris Medical$28M · 2026-03-12
Bruce Macfarlane
Current Health$43M · 2021-04-22
Epitel$12M · 2022-02-16
CU Healthcare Innovation Fund- Monteris Medical$28M · 2026-03-12
- Epitel$12M · 2022-02-16
InnovaHealth Partners- Monteris Medical$28M · 2026-03-12
Lux Capital
Cala Health$50M · 2024-12-09
Madryn Asset Management- Monteris Medical$28M · 2026-03-12
Norwest Venture Partners
ShiraTronics$66M · 2024-10-09
TDK Ventures
Exo Imaging$40M · 2020-08-20
U.S. Venture Partners- ShiraTronics$66M · 2024-10-09
Zack Scott- ShiraTronics$66M · 2024-10-09
Investments
| $28M2026-03-12 | Monteris Medical | InnovaHealth Partners, Birchview Capital, CU Healthcare Innovation Fund, Madryn Asset Management, OSF Ventures |
| $50M2024-12-09 | Cala Health | Lux Capital, OSF Ventures |
| $66M2024-10-09 | ShiraTronics | Norwest Venture Partners, Zack Scott, OSF Ventures, U.S. Venture Partners |
| $75M2022-08-23 | Digital Diagnostics | 8VC, OSF Ventures |
| $12M2022-02-16 | Epitel | Genoa Ventures, Catalyst Health Ventures, OSF Ventures |
| $43M2021-04-22 | Current Health | Bruce Macfarlane, OSF Ventures |
| $40M2020-08-20 | Exo Imaging | TDK Ventures, OSF Ventures |
| $35M2019-08-12 | Exo Imaging | OSF Ventures |
| $—Unknown date |  Health Catalyst | OSF Ventures |
| $—Unknown date |  Inflammatix, Inc. | OSF Ventures |